2
|
Arcani R, Velier M, Sabatier F, Simoncini S, Abellan-Lopez M, Granel B, Benyamine A, Gomes de Pinho Q, Dani V, Gentile P, Magalon G, Menkes S, Sampson S, Verpaele A, Vonk L, Magalon J, Daumas A. Nanofat Use in Regenerative Medicine: A Systematic Literature Review and Consensus Recommendations from Expert Opinions. Facial Plast Surg Aesthet Med 2025. [PMID: 40250993 DOI: 10.1089/fpsam.2024.0385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/20/2025] Open
Abstract
Objective: To report in vitro, preclinical, and clinical effectiveness of nanofat in adults undergoing reconstructive or functional surgery and to produce a series of consensus statements about nanofat definition by experts. Methods: We conducted a systematic review using PubMed and Web of Science database, retaining studies about nanofat alone. To produce consensus recommendations about nanofat, we invited experts to answer a survey about manufacturing, biological characteristics, and nomenclature of nanofat. Results: A review of 39 articles showed that nanofat seems to have strong regenerative potential. There were 16 studies about the clinical effectiveness of the nanofat in wound healing, aesthetic surgery, and functional disabilities. However, majority of applications lack robust clinical evidence, mainly due to the design of the clinical studies. The experts suggested that nanofat refers to lipoaspirate that benefits from a washing step, followed by emulsification (20-30 passes) with a connector size between 1.2 and 1.6 mm, and a final filtration step (pore size around 300-500 µm). Conclusion: Nanofat seems to have strong regenerative potentials but with a lack of robust clinical evidences. Our experts have suggested the first consensus about a definition of the nanofat that can be used by the academic societies in the coming years.
Collapse
Affiliation(s)
- Robin Arcani
- Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
| | - Mélanie Velier
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC, Marseille, France
| | - Florence Sabatier
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC, Marseille, France
| | - Stéphanie Simoncini
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
| | - Maxime Abellan-Lopez
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Plastic Surgery Department, Hôpital de la Conception, AP-HM, Marseille, France
| | - Brigitte Granel
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Internal Medicine Department, Hôpital Nord AP-HM, Marseille, France
| | - Audrey Benyamine
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Internal Medicine Department, Hôpital Nord AP-HM, Marseille, France
| | - Quentin Gomes de Pinho
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Internal Medicine Department, Hôpital Nord AP-HM, Marseille, France
| | | | - Pietro Gentile
- Department of Surgical Science, Medical School, "Tor Vergata" University, Rome, Italy
| | | | | | - Steve Sampson
- The Orthohealing Center, Los Angeles, California, USA
| | - Alexis Verpaele
- Tonnard and Verpaele Plastic Surgery Associates, Ghent, Belgium
| | - Lucienne Vonk
- Department of Orthopaedics, University Medical Center Utrecht, Utrecht, The Netherlands & Xintela AB, Lund, Sweden
| | - Jérémy Magalon
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
- Cell Therapy Department, Hôpital de la Conception, AP-HM, INSERM CIC, Marseille, France
| | - Aurélie Daumas
- Internal Medicine and Therapeutics Department, CHU La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France
- Center for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S 1263, Aix-Marseille University, Marseille, France
| |
Collapse
|
3
|
Li X, Guo F, Deng J, Li J, Zhang J, Fu M, Fan H. Leukocyte Platelet-Rich Plasma-Derived Exosomes Restrained Macrophages Viability and Induced Apoptosis, NO Generation, and M1 Polarization. Immun Inflamm Dis 2024; 12:e70064. [PMID: 39545659 PMCID: PMC11565605 DOI: 10.1002/iid3.70064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2024] [Revised: 10/16/2024] [Accepted: 10/30/2024] [Indexed: 11/17/2024] Open
Abstract
BACKGROUND Chronic refractory wounds refer to wounds that cannot be repaired timely. Platelet-rich plasma (PRP) has significant potential in chronic wound healing therapy. The exosomes isolated from PRP were proved to exhibit more effectiveness than PRP. However, the therapeutic potential of exosomes from PRP on chronic refractory wounds remained elusive. Hence, this study aimed to clarify the action of exosomes from PRP on chronic refractory wounds by evaluating the response of macrophages to exosomes. METHODS Pure platelet-rich plasma (P-PRP) and leukocyte platelet-rich plasma (L-PRP) were prepared from the fasting venous blood of healthy volunteers. Exosomes were extracted from P-PRP and L-PRP using ultracentrifugation and identified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blot. Macrophages were obtained by inducing THP-1 cells with phorbol-12-myristate-13 acetate (PMA). The internalization of exosomes into macrophages was observed utilizing confocal laser scanning microscopy after being labeled with PKH67. Cell viability was determined by CCK-8 assay. Cell apoptosis was measured utilizing a flow cytometer. The polarization status of M1 and M2 macrophages were evaluated by detecting their markers. Nitric oxide (NO) detection was conducted using the commercial kit. RESULTS Exosomes from P-PRP and L-PRP were absorbed by macrophages. Exosomes from L-PRP restrained viability and induced apoptosis of macrophages. Besides, exosomes from P-PRP promoted M2 polarization, and exosomes from L-PRP promoted M1 polarization. Furthermore, exosomes from L-PRP promoted NO generation of macrophages. CONCLUSION Exosomes from L-PRP restrained viability, induced apoptosis and NO generation of macrophages, and promoted M1 polarization, while exosomes from P-PRP increased M2 polarization. The exosomes from L-PRP presented a more effective effect on macrophages than that from P-PRP, making it a promising strategy for chronic refractory wound management.
Collapse
Affiliation(s)
- Xiong Li
- Department of Plastic and Aesthetic SurgeryThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| | - Feifei Guo
- Department of Health Management CentreThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| | - Jiehua Deng
- Department of Plastic and Aesthetic SurgeryThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| | - Jiasong Li
- Department of Plastic and Aesthetic SurgeryThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| | - Jie Zhang
- Department of Plastic and Aesthetic SurgeryThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| | - Ming Fu
- Department of Plastic and Aesthetic SurgeryThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| | - Hui Fan
- Department of OtolaryngologyThe Second Affiliated Hospital of Guilin Medical UniversityGuilinChina
| |
Collapse
|
4
|
Huang P, He Y, Huang C, Jiang S, Gan J, Wu R, Ai C, Huang J, Yao C, Chen Q. MOF@platelet-rich plasma antimicrobial GelMA dressing: structural characterization, bio-compatibility, and effect on wound healing efficacy. RSC Adv 2024; 14:30055-30069. [PMID: 39309655 PMCID: PMC11413862 DOI: 10.1039/d4ra04546g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2024] [Accepted: 09/11/2024] [Indexed: 09/25/2024] Open
Abstract
In this study, a metal-organic framework (MOF) antimicrobial gel loaded with platelet-rich plasma (PRP) was prepared to improve the biological properties of gelatin gels and enhance their wound healing efficiency. PRP, MOF particles, and PRP-loaded MOF particles were each integrated into gelatin gels. The performance of the gels was evaluated for micro-structure, mechanical strength, in vitro bio-compatibility and pro-wound healing effects. The results revealed that the integration of PRP created a multi-cross-linked structure, increasing the ductility of the gels by over 40%. The addition of MOF particles significantly increased the strength of the gel from 13 kPa to 43 kPa. The combination of MOF and PRP further improved the cell induction and migration capabilities of the composite gel, and the scratches in the PRP/MOF@GelMA group had completely healed within 48 h. Due to the presence of MOF and PRP, the gel dressing exhibited inhibitory effects of 45.7% against Staphylococcus aureus (S. aureus) and 50.2% against Escherichia coli (E. coli). Different gels promoted tissue regeneration and wound healing ability of bacterial-infected wounds in C57 rats, while PRP/MOF@GelMA showed the strongest wound repair ability with 100% healing. This study provides a new strategy for the development and clinical application of gel dressings.
Collapse
Affiliation(s)
- Pengyu Huang
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
- Department of Gastroenterology, People's Hospital of Guangxi Zhuang Autonomous Region Nanning 530021 Guangxi P. R. China
| | - Yongan He
- Department of Gastroenterology, The People's Hospital of Chongzuo Chongzuo 532200 Guangxi P. R. China
| | - Chunnuan Huang
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| | - Shuhan Jiang
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| | - Ji Gan
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| | - Rong Wu
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| | - Chengjiao Ai
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| | - Jiean Huang
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| | - Chaoguang Yao
- Department of Gastroenterology, Hechi People's Hospital Hechi 547000 Guangxi P. R. China
| | - Quanzhi Chen
- School of Basic Medical Sciences, The Second Affiliated Hospital, Guangxi Medical University Nanning 530021 Guangxi P. R. China
| |
Collapse
|
5
|
Zhuang J, Chen Y, Zheng X, Wang C, Hu J, Liu T. The Application of Blood Products in Plastic Surgery: A Systematic Review. PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN 2024; 12:e6005. [PMID: 39050033 PMCID: PMC11268820 DOI: 10.1097/gox.0000000000006005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2024] [Accepted: 05/31/2024] [Indexed: 07/27/2024]
Abstract
Background Due to their minimal trauma and relative safety, blood products are becoming increasingly popular in medical aesthetics. In recent years, research on the application of blood products has also been increased. This article will summarize the research progress of emerging blood products in plastic surgery in recent years. Methods We searched the PubMed database for literature related to the application of blood preparation in plastic surgery over the past 5 years and summarized them. Results Commonly used in plastic surgery are platelet-rich plasma, platelet-rich fibrin, concentrated growth factor, platelet-poor plasma, and mesenchymal stem cells derived from blood products. They can be used for wound repair and skin and autologous fat transplantation, and can be combined with laser therapy and facial rejuvenation. Conclusions Understanding the application pathways of blood products in plastic surgery and their respective advantages and disadvantages can help us better choose and use them.
Collapse
Affiliation(s)
- Jun Zhuang
- From the Department of Ear Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yi Chen
- Department of Endocrinology, Air Force Medical Hospital, Beijing, China
- Graduate School of China Medical University, Shenyang, China
| | | | - Cheng Wang
- Zhejiang Chinese Medical University, Hangzhou, China
| | - Jintian Hu
- Department of Cosmetic Injection Center, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Tun Liu
- From the Department of Ear Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|